Re: Safety and Tolerability of Fesoterodine in Older Adult Patients with Overactive Bladder

被引：0
|
作者：
Kaplan, Steven A.
机构：
来源：
JOURNAL OF UROLOGY | 2022年 / 208卷 / 04期
关键词：
D O I：
10.1097/JU.0000000000002868
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：908 / 908
页数：1
相关论文
共 50 条
  • [1] Safety and Tolerability of Fesoterodine in Older Adult Patients with Overactive Bladder
    Heesakkers, John
    Te Dorsthorst, Manon
    Wagg, Adrian
    CANADIAN GERIATRICS JOURNAL, 2022, 25 (01) : 72 - 78
  • [2] Efficacy, Safety and Tolerability of Fesoterodine in Asian Patients with Overactive Bladder
    Yamaguchi, Osamu
    Nishizawa, Osamu
    Takeda, Masayuki
    Yoshida, Masaki
    Choo, Myung-Soo
    Lee, Jeong Gu
    Lin, Alex Tong-Long
    Lin, Ho-Hsiung
    Yip, Wai-Chun Andrew
    Isowa, Hitoshi
    Hiro, Shintaro
    LUTS-LOWER URINARY TRACT SYMPTOMS, 2011, 3 (01) : 43 - 50
  • [3] Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome
    Nitti, Victor W.
    Dmochowski, Roger
    Sand, Peter K.
    Forst, Hans-Theo
    Haag-Molkenteller, Cornelia
    Massow, Ute
    Wang, Joseph
    Brodsky, Marina
    Bavendam, Tamara
    JOURNAL OF UROLOGY, 2007, 178 (06): : 2488 - 2494
  • [4] Efficacy and Tolerability of Fesoterodine in Older and Younger Subjects With Overactive Bladder
    Kraus, Stephen R.
    Luis Ruiz-Cerda, Jose
    Martire, Diane
    Wang, Joseph T.
    Wagg, Adrian S.
    UROLOGY, 2010, 76 (06) : 1350 - 1357
  • [5] Efficacy and Tolerability of Fesoterodine in Older Subjects With Overactive Bladder: Results of SOFIA
    Wagg, A. S.
    Khullar, V.
    Marschall-Kehrel, D.
    Michel, M. C.
    Oelke, M.
    Darekar, A.
    Bitoun, C. Ebel
    Osterloh, I.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2011, 59 : S124 - S124
  • [6] Efficacy and tolerability of fesoterodine in women with overactive bladder
    Sand, Peter K.
    Morrow, Jon D.
    Bavendam, Tamara
    Creanga, Dana L.
    Nitti, Victor W.
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2009, 20 (07) : 827 - 835
  • [7] Efficacy and tolerability of fesoterodine in women with overactive bladder
    Peter K. Sand
    Jon D. Morrow
    Tamara Bavendam
    Dana L. Creanga
    Victor W. Nitti
    International Urogynecology Journal, 2009, 20 : 827 - 835
  • [8] THREE-YEAR SAFETY, TOLERABILITY, AND EFFICACY OF FESOTERODINE TREATMENT IN SUBJECTS WITH OVERACTIVE BLADDER
    Van Kerrebroeck, P. E. V.
    Heesakkers, J.
    Berriman, S.
    Aiyer, L. P.
    Carlsson, M.
    Guan, Z.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (04) : 167 - 167
  • [9] Clinical efficacy, safety, and tolerability of once-daily fesoterodine in subjects with overactive bladder
    Chapple, Christopher
    Van Kerrebroeck, Philip
    Tubaro, Andrea
    Haag-Molkenteller, Cornelia
    Forst, Hans-Theo
    Massow, Ute
    Wang, Joseph
    Brodsky, Marina
    EUROPEAN UROLOGY, 2007, 52 (04) : 1204 - 1212
  • [10] Efficacy, safety, and tolerability of fesoterodine in patients with overactive bladder: A phase 3 placebo controlled trial in the United States
    Nitti, VW
    Dmochowski, RR
    Williams, T
    Alvarez-Jacinto, OR
    JOURNAL OF UROLOGY, 2006, 175 (04): : 57 - 57
12345